Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: resu... von Byrd, John C., Peterson, Bercedis L., Morrison, Vicki A., Park, Kathleen, Jacobson, Robert, Hoke, Eva, Vardiman, James W., Rai, Kanti, Schiffer, Charles A., Larson, Richard A.

Volltext

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine von Blum, William, Garzon, Ramiro, Klisovic, Rebecca B, Schwind, Sebastian, Walker, Alison, Geyer, Susan, Liu, Shujun, Havelange, Violaine, Becker, Heiko, Schaaf, Larry, Mickle, Jon, Devine, Hollie, Kefauver, Cheryl, Devine, Steven M, Chan, Kenneth K, Heerema, Nyla A, Bloomfield, Clara D, Grever, Michael R, Byrd, John C, Villalona-Calero, Miguel, Croce, Carlo M, Marcucci, Guido

Volltext

Adult Burkitt leukemia and lymphoma von Blum, Kristie A., Lozanski, Gerard, Byrd, John C.

Volltext

Mucins and mucin binding proteins in colorectal cancer: Colorectal cancer von BVRD, James C, BRESALIER, Robert S

Volltext

Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocyticleukaemia treated with ibrutinib from 3 clinical trials von Jones, J, Mato, A, Coutre, S, Byrd, JC, Furman, RR, Hillmen, P, Osterborg, A, Tam, C, Stilgenbauer, S, Wierda, WG

Volltext

Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials von Jones, Jeffrey, Mato, Anthony, Coutre, Steven, Byrd, John C., Furman, Richard R., Hillmen, Peter, Osterborg, Anders, Tam, Constantine, Stilgenbauer, Stephan, Wierda, William G., Heerema, Nyla A., Eckert, Karl, Clow, Fong, Zhou, Cathy, Chu, Alvina D., James, Danelle F., O'Brien, Susan M.

Volltext

ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia von Rassenti, Laura Z, Huynh, Lang, Toy, Tracy L, Chen, Liguang, Keating, Michael J, Gribben, John G, Neuberg, Donna S, Flinn, Ian W, Rai, Kanti R, Byrd, John C, Kay, Neil E, Greaves, Andrew, Weiss, Arthur, Kipps, Thomas J

Volltext

Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia von Blum, William, Schwind, Sebastian, Tarighat, Somayeh S., Geyer, Susan, Eisfeld, Ann-Kathrin, Whitman, Susan, Walker, Alison, Klisovic, Rebecca, Byrd, John C., Santhanam, Ramasamy, Wang, Hongyan, Curfman, John P., Devine, Steven M., Jacob, Samson, Garr, Celia, Kefauver, Cheryl, Perrotti, Danilo, Chan, Kenneth K., Bloomfield, Clara D., Caligiuri, Michael A., Grever, Michael R., Garzon, Ramiro, Marcucci, Guido

Volltext

Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retro... von Byrd, John C., Rai, Kanti, Peterson, Bercedis L., Appelbaum, Frederick R., Morrison, Vicki A., Kolitz, Jonathan E., Shepherd, Lois, Hines, John D., Schiffer, Charles A., Larson, Richard A.

Volltext

Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma von Rosko, A, Hofmeister, C, Benson, D, Efebera, Y, Huang, Y, Gillahan, J, Byrd, J C, Burd, C E

Volltext

A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia von Byrd, John C., Marcucci, Guido, Parthun, Mark R., Xiao, Jim J., Klisovic, Rebecca B., Moran, Mollie, Lin, Thomas S., Liu, Shujun, Sklenar, Amy R., Davis, Melanie E., Lucas, David M., Fischer, Beth, Shank, Roshini, Tejaswi, Sooraj L., Binkley, Philip, Wright, John, Chan, Kenneth K., Grever, Michael R.

Volltext

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leuke... von Byrd, John C., Mrózek, Krzysztof, Dodge, Richard K., Carroll, Andrew J., Edwards, Colin G., Arthur, Diane C., Pettenati, Mark J., Patil, Shivanand R., Rao, Kathleen W., Watson, Michael S., Koduru, Prasad R.K., Moore, Joseph O., Stone, Richard M., Mayer, Robert J., Feldman, Eric J., Davey, Frederick R., Schiffer, Charles A., Larson, Richard A., Bloomfield, Clara D.

Volltext

Select High-Risk Genetic Features Predict Earlier Progression Following Chemoimmunotherapy With Fludarabine and Rituximab in Chronic Lymphocytic Leukemia: Justification for Risk-Ad... von BYRD, John C, GRIBBEN, John G, PETERSON, Bercedis L, GREVER, Michael R, LOZANSKI, Gerard, LUCAS, David M, LAMPSON, Ben, LARSON, Richard A, CALIGIURI, Michael A, HEEREMA, Nyla A

Volltext

Circulating miRNA markers show promise as new prognosticators for multiple myeloma von Rocci, A, Hofmeister, C C, Geyer, S, Stiff, A, Gambella, M, Cascione, L, Guan, J, Benson, D M, Efebera, Y A, Talabere, T, Dirisala, V, Smith, E M, Omedè, P, Isaia, G, De Luca, L, Rossi, D, Gentili, S, Uccello, G, Consiglio, J, Ria, R, Benevolo, G, Bringhen, S, Callea, V, Weiss, B, Ferro, A, Magarotto, V, Alder, H, Byrd, J C, Boccadoro, M, Marcucci, G, Palumbo, A, Pichiorri, F

Volltext

The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction von Byrd, John C., Kitada, Shinichi, Flinn, Ian W., Aron, Jennifer L., Pearson, Michael, Lucas, David, Reed, John C.

Volltext

Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions von Lozanski, Gerard, Heerema, Nyla A., Flinn, Ian W., Smith, Lisa, Harbison, Jennifer, Webb, Jennifer, Moran, Mollie, Lucas, Margaret, Lin, Thomas, Hackbarth, Marcy L., Proffitt, John H., Lucas, David, Grever, Michael R., Byrd, John C.

Volltext

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia von Rosenwald, A, Alizadeh, A A, Widhopf, G, Simon, R, Davis, R E, Yu, X, Yang, L, Pickeral, O K, Rassenti, L Z, Powell, J, Botstein, D, Byrd, J C, Grever, M R, Cheson, B D, Chiorazzi, N, Wilson, W H, Kipps, T J, Brown, P O, Staudt, L M

Volltext

Apoptotic-Regulatory and Complement-Protecting Protein Expression in Chronic Lymphocytic Leukemia: Relationship to In Vivo Rituximab Resistance von BANNERJI, Rajat, KITADA, Shinichi, FLINN, Ian W, PEARSON, Michael, YOUNG, Donn, REED, John C, BYRD, John C

Volltext

Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse von Braggio, E, Kay, N E, VanWier, S, Tschumper, R C, Smoley, S, Eckel-Passow, J E, Sassoon, T, Barrett, M, Van Dyke, D L, Byrd, J C, Jelinek, D F, Shanafelt, T D, Fonseca, R

Volltext

CpG island methylation and expression of the secreted frizzled- related protein gene family in chronic lymphocytic leukemia von LIU, Te-Hui, RAVAL, Aparna, CHEN, Shih-Shih, MATKOVIC, Jennifer J, BYRD, John C, PLASS, Christoph

Volltext